NCT01712490 2026-02-27A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin LymphomaTakedaPhase 3 Completed1,334 enrolled 23 charts
NCT01060904 2014-12-18A Phase 1 Study of Brentuximab Vedotin Combined With Multi-Agent Chemotherapy for Hodgkin LymphomaSeagen Inc.Phase 1 Completed51 enrolled